149 related articles for article (PubMed ID: 31663663)
1. Functional analysis of RPS27 mutations and expression in melanoma.
Floristán A; Morales L; Hanniford D; Martinez C; Castellano-Sanz E; Dolgalev I; Ulloa-Morales A; Vega-Saenz de Miera E; Moran U; Darvishian F; Osman I; Kirchhoff T; Hernando E
Pigment Cell Melanoma Res; 2020 May; 33(3):466-479. PubMed ID: 31663663
[TBL] [Abstract][Full Text] [Related]
2. A highly recurrent RPS27 5'UTR mutation in melanoma.
Dutton-Regester K; Gartner JJ; Emmanuel R; Qutob N; Davies MA; Gershenwald JE; Robinson W; Robinson S; Rosenberg SA; Scolyer RA; Mann GJ; Thompson JF; Hayward NK; Samuels Y
Oncotarget; 2014 May; 5(10):2912-7. PubMed ID: 24913145
[TBL] [Abstract][Full Text] [Related]
3. CFTR modulates RPS27 gene expression using chloride anion as signaling effector.
Valdivieso ÁG; Mori C; Clauzure M; Massip-Copiz M; Santa-Coloma TA
Arch Biochem Biophys; 2017 Nov; 633():103-109. PubMed ID: 28941802
[TBL] [Abstract][Full Text] [Related]
4. Neddylation modification of ribosomal protein RPS27L or RPS27 by MDM2 or NEDP1 regulates cancer cell survival.
Xiong X; Cui D; Bi Y; Sun Y; Zhao Y
FASEB J; 2020 Oct; 34(10):13419-13429. PubMed ID: 32779270
[TBL] [Abstract][Full Text] [Related]
5. Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia.
Wang R; Yoshida K; Toki T; Sawada T; Uechi T; Okuno Y; Sato-Otsubo A; Kudo K; Kamimaki I; Kanezaki R; Shiraishi Y; Chiba K; Tanaka H; Terui K; Sato T; Iribe Y; Ohga S; Kuramitsu M; Hamaguchi I; Ohara A; Hara J; Goi K; Matsubara K; Koike K; Ishiguro A; Okamoto Y; Watanabe K; Kanno H; Kojima S; Miyano S; Kenmochi N; Ogawa S; Ito E
Br J Haematol; 2015 Mar; 168(6):854-64. PubMed ID: 25424902
[TBL] [Abstract][Full Text] [Related]
6. RPS27 selectively regulates the expression and alternative splicing of inflammatory and immune response genes in thyroid cancer cells.
Wan J; Lv J; Wang C; Zhang L
Adv Clin Exp Med; 2022 Aug; 31(8):889-901. PubMed ID: 35546566
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal protein S27L is a direct p53 target that regulates apoptosis.
He H; Sun Y
Oncogene; 2007 Apr; 26(19):2707-16. PubMed ID: 17057733
[TBL] [Abstract][Full Text] [Related]
8. The Chloride Anion Acts as a Second Messenger in Mammalian Cells - Modifying the Expression of Specific Genes.
Valdivieso ÁG; Clauzure M; Massip-Copiz M; Santa-Coloma TA
Cell Physiol Biochem; 2016; 38(1):49-64. PubMed ID: 26741366
[TBL] [Abstract][Full Text] [Related]
9. Somatic driver mutations in melanoma.
Reddy BY; Miller DM; Tsao H
Cancer; 2017 Jun; 123(S11):2104-2117. PubMed ID: 28543693
[TBL] [Abstract][Full Text] [Related]
10. Conservation of multifunctional ribosomal protein metallopanstimulin-1 (RPS27) through complex evolution demonstrates its key role in growth regulation in Archaea, eukaryotic cells, DNA repair, translation and viral replication.
Fernandez-Pol JA
Cancer Genomics Proteomics; 2011; 8(3):105-26. PubMed ID: 21518817
[TBL] [Abstract][Full Text] [Related]
11. Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin β4.
Yang ZY; Jiang H; Qu Y; Wei M; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
Carcinogenesis; 2013 Dec; 34(12):2851-60. PubMed ID: 23803695
[TBL] [Abstract][Full Text] [Related]
12. Extraribosomal function of metallopanstimulin-1: reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth.
Dai Y; Pierson SE; Dudney WC; Stack BC
Int J Cancer; 2010 Feb; 126(3):611-9. PubMed ID: 19642098
[TBL] [Abstract][Full Text] [Related]
13. Analysis of SDHD promoter mutations in various types of melanoma.
Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
[TBL] [Abstract][Full Text] [Related]
14. Subfunctionalized expression drives evolutionary retention of ribosomal protein paralogs
Xu AF; Molinuevo R; Fazzari E; Tom H; Zhang Z; Menendez J; Casey KM; Ruggero D; Hinck L; Pritchard JK; Barna M
Elife; 2023 Jun; 12():. PubMed ID: 37306301
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal protein S27-like in colorectal cancer: a candidate for predicting prognoses.
Huang CJ; Yang SH; Lee CL; Cheng YC; Tai SY; Chien CC
PLoS One; 2013; 8(6):e67043. PubMed ID: 23826192
[TBL] [Abstract][Full Text] [Related]
16. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of metallopanstimulin-1 inhibits NF-κB signaling at different levels: the role of apoptosis induction of gastric cancer cells.
Yang ZY; Qu Y; Zhang Q; Wei M; Liu CX; Chen XH; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
Int J Cancer; 2012 Jun; 130(12):2761-70. PubMed ID: 21796632
[TBL] [Abstract][Full Text] [Related]
19. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome.
Poulos RC; Thoms JA; Shah A; Beck D; Pimanda JE; Wong JW
Mol Cancer Res; 2015 Aug; 13(8):1218-26. PubMed ID: 26082173
[TBL] [Abstract][Full Text] [Related]
20. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
